| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.7 |